Can-Fite BioPharma Ltd. ROA Ratio 2011-2026 | CANF

Annual ROA Ratio Can-Fite BioPharma Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-86.4	-76.42	-109.59	-62.29	-151.66	-154.45	-82.63	63.75	69.09	28.78	240.74	-125.73	-340.81	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
240.74	-340.81	-60.59

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Graybug Vision GRAY	-217.51	-	-11.23 %	$ 9.65 M	USA
AbCellera Biologics ABCL	-10.79	$ 3.67	-1.21 %	$ 1.1 B	Canada
ADMA Biologics ADMA	23.54	$ 16.57	1.16 %	$ 3.95 B	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Apellis Pharmaceuticals APLS	2.08	$ 19.98	-0.87 %	$ 2.52 B	USA
Aptorum Group Limited APM	-26.46	$ 0.8	1.03 %	$ 4.36 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	-150.49	-	-11.43 %	$ 502 K	USA
Athersys ATHX	-144.48	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	-50.64	-	-	$ 521 M	USA
Brainstorm Cell Therapeutics BCLI	-634.44	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	5.51	$ 8.39	-1.87 %	$ 1.39 B	Britain
Axsome Therapeutics AXSM	-26.55	$ 165.17	0.68 %	$ 8.22 B	USA
BridgeBio Pharma BBIO	-78.3	$ 65.96	2.22 %	$ 12.6 B	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	-24.24	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Avid Bioservices CDMO	-41.82	-	-	$ 789 M	USA
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
BioLineRx Ltd. BLRX	-33.24	$ 2.84	1.07 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	4.59	$ 60.93	4.1 %	$ 11.7 B	USA
Checkpoint Therapeutics CKPT	-752.78	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-57.1	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	-20.15	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	-55.94	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	-77.89	-	-	$ 231 M	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	-73.85	-	-	$ 1.2 B	USA
CohBar CWBR	-74.39	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	-273.86	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	-273.86	-	-4.36 %	$ 27 M	USA
Cabaletta Bio CABA	-26.68	$ 3.38	4.0 %	$ 3.95 M	USA
Deciphera Pharmaceuticals DCPH	-41.16	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Capricor Therapeutics CAPR	-37.95	$ 26.52	2.63 %	$ 710 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-123.72	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	-43.81	$ 1.08	9.69 %	$ 79.3 M	USA
Certara CERT	-0.1	$ 7.26	0.21 %	$ 1.16 B	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Coherus BioSciences CHRS	-37.78	$ 1.78	7.96 %	$ 168 M	USA
Entasis Therapeutics Holdings ETTX	-115.2	-	-	$ 105 M	USA
Evofem Biosciences EVFM	501.98	-	7.55 %	$ 38.1 M	USA